-
effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
September 02, 2013 - Case reports are hypothesis generating rather than hypothesis testing. … Cohort and case-control studies are well suited for testing hypotheses of whether one intervention is … Cohort and case-control studies are well suited for testing hypotheses that one intervention is associated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
September 02, 2013 - Case reports are hypothesis generating rather than hypothesis testing. … Cohort and case-control studies are well suited for testing hypotheses of whether one intervention is … Cohort and case-control studies are well suited for testing hypotheses that one intervention is associated
-
effectivehealthcare.ahrq.gov/health-topics/liver-function-tests
-
effectivehealthcare.ahrq.gov/health-topics/blood-count-tests/
-
effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_educatingsessionparticipants.pdf
May 18, 2012 - questioning by participants
– Problem – may assume adversarial positions
• Pretesting, cognitive testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
February 01, 2012 - Clinical testing of
high-spatial-resolution parametric contrast-enhanced MR imaging
of the breast.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
September 29, 2010 - Protocol
Project Title: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-
Citrullinated Peptide Testing … No systematic reviews examining ANA for pediatric SLE or RF and
CCP testing for JIA were identified … of symptoms
KQ.3: What are the diagnostic performance characteristics of the ANA, RF, and CCP testing … Antinuclear antibody (ANA) testing. Pediatr Rev 2003;24:320-1.
4. Syed RH, Gilliam BE, Moore TL. … Anti-CCP antibody testing as a diagnostic and
prognostic tool in rheumatoid arthritis.
-
effectivehealthcare.ahrq.gov/health-topics/mental-health
April 03, 2014 - September 30, 2012
Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
February 01, 2008 - Largely because of widespread PSA
testing, the lifetime risk of being detected
with prostate cancer in … PSA testing detects
more tumors, at an earlier stage, with smaller volume
within each stage, and at an … Few enrolled men had prostate cancers
waiting detected by PSA testing. … Prostate cancers not
detected by PSA testing. … Only 5% of enrollees had prostate cancer detected by PSA
testing.
-
effectivehealthcare.ahrq.gov/products/sleep-apnea/research-protocol
March 15, 2010 - Preoperative testing
People with sleep apnea are at increased risk of surgical and anesthesia-related … KQ3: How does phased testing (screening tests or battery followed by full test) compare to full testing … Key question 3 evaluates phased testing. We will not otherwise review the order of testing. … covered in the systematic review (in background material / introduction of report)
KQ 2
Formal testing … For program testing and training purposes, we will manually screen 1000 abstracts, each twice.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
July 01, 2012 - medical test review are: to identify and
synthesize evidence to evaluate the impacts of alternative testing … The analytic framework was of limited value, as several
possible relevant testing strategies were not … The testing strategy in the lower portion of the decision
tree entails performing biopsy in all patients … Noninvasive carotid artery testing. A meta-
analytic review. … HER2 Testing to Manage Patients With
Breast Cancer or Other Solid Tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - standard
tools for grading evidence were designed for questions about treatment rather than
diagnostic testing … The degree of harms from false positives depends on the invasiveness of further testing or
treatment … versus not testing is a toss-up—where net
benefits are equivalent to net harms. … The impact of plausible unmeasured confounders may
be relevant to testing strategies that predict outcomes … Outcomes of Genetic Testing in Adults with a
History of Venous Thromboembolism.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
January 08, 2013 - CER #50:
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating
Musculoskeletal Complaints in Children
Original release date:
March, 2012
Surveillance Report:
March, 2013
Key Findings:
- All conclusions from the original CER are up to date.
Summary Decisio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
March 01, 2012 - 1
Comparative Effectiveness Review
Number 50
Antinuclear Antibody, Rheumatoid Factor, and
Cyclic-Citrullinated Peptide Tests for Evaluating
Musculoskeletal Complaints in Children
Executive Summary
Background
Musculoskeletal (MSK) pain is common
in children and adolescents, with an
estimated prevalence rangin…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
May 01, 2024 - Additionally, owing to the
overlapping findings of the C. difficile testing chapter in MHS III, our … rapid response
also subsumes the C. difficile surveillance and testing topics as they relate to ASC … difficile testing in 2017 has led to an acceleration in publications evaluating C. difficile
testing … Holding firm: Use of
clinical correlation to improve Clostridioides difficile testing. … , time to testing, and mandatory reporting.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
March 07, 2012 - We have indicated that IIF is the gold standard for ANA
testing and have referenced the ACR consensus … I am not sure that the authors have a clear
understanding of ANA testing. … the
utility of ANA testing in children with MSK pain. … We have reworded the introduction to address changes
in ANA testing (p 2-3). … The authors do not address the issue
of changes in ANA testing at all.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
December 01, 2015 - Rationale for Evidence Review
Accurate testing of patients presenting with symptoms
consistent with … For the populations listed under Key Question 1a,
what is the effect of alternative testing strategies … What factors modify the comparative effectiveness
of testing for patients with RLQ pain and suspected … It is likely that the lack of
separation between the training and testing datasets led
to optimistic … Adverse Events of Testing
Information on harms was often incomplete and poorly
reported.
-
effectivehealthcare.ahrq.gov/health-topics/skin-conditions
December 08, 2017 - Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin
Systematic Review
December 8, 2017
Technical Brief: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques
Research Protocol
Archived
August 23, 2010
Systematic Review of Treatments f…
-
effectivehealthcare.ahrq.gov/health-topics/breast-diseases
February 13, 2012 - Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review
Systematic Review
Archived
February 13, 2012
Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities
Systematic Review
Archived
February 9, 2006
Data Points #14: Use of endocrine t…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
July 01, 2012 - what it measures,
how it is done, how clinical specimens are obtained, processed, and stored for testing … What is the applicable testing scenario? … Cost effectiveness: Do the improvements in patient outcomes justify the additional costs
of testing … Were the subjects somehow referred or selected for testing? What was the testing scenario?
3.